[1] 中华预防医学会. 中国脑膜炎球菌疫苗预防接种专家共识 (2023 年版)[J]. 中国疫苗和免疫,2023,29 (1): 90-101. [2] 苏颖,陈霞,王斌冰,等. 安徽省 3~18 岁健康儿童青少年脑膜炎奈瑟菌带菌状况 [J]. 中国学校卫生,2024,45 (6): 878-881. [3] Alderson MR, Arkwright PD, Bai X, et al. Surveillance and control of meningococcal disease in the COVID-19 era: A global meningococcal initiative review[J]. J Infect, 2022, 84(3): 289-296. [4] 唐莹,王凤双,李春龙,等. 北京市某区不同出生队列 6~35 月龄儿童流脑疫苗基础免疫接种情况及影响因素分析 [J]. 职业与健康,2024,40 (22): 3073-3077. [5] 胡伟军,王锐泽,王月祺,等. 陕西省健康人群脑膜炎奈瑟菌带菌率调查及其血清群分布特征 [J]. 实用医学杂志,2020,36 (6): 796-800. [6] 李军宏,吴丹,尹遵栋,等. 2015—2017 年中国流行性脑脊髓膜炎流行特征分析[J]. 中华预防医学杂志,2019,53 (2): 159-163. [7] 哈力木别克·那扎尔别克,符文慧,兰兆国,等. 2011—2022 年新疆维吾尔自治区南疆地区流行性脑脊髓膜炎流行病学特征及健康人群携带状况调查[J]. 疾病监测,2024,39 (7): 841-845. [8] Kristinsdottir I, Visser LJ, Miellet WR, et al. Meningococcal carriage in children and young adults: A cross-sectional and longitudinal study, Iceland, 2019 to 2021[J]. Euro Surveill, 2023, 28(39): 2300215. [9] Yildiz P, Sahin TM, Kaya M, et al. Nasopharyngeal meningococcal carriage among older adults in Türkiye (MeningOld study)[J]. Microorganisms, 2023, 11(8): 2095. [10] Olof S, Lorraine E, Berhane AI, et al. Neisseria meningitidis prevalence and persistence of carriage in Swedish university students[J]. Epidemiol Infect, 2023, 151: e25. [11] 胡奇胆,胡智强,林建阳,等. 2024 年福建省首例 Y 群流行性脑脊髓膜炎病例调查处置[J]. 中国疫苗和免疫,2024,30 (5): 568-571. [12] 王珊,杜照中,尹强,等. 2017—2019 年济宁市健康人群脑膜炎奈瑟菌流行病学和基因组学分析[J]. 中国人兽共患病学报,2023,39 (9): 879-886. [13] 陈晨,任远,郭妮,等. 云南省保山市健康人群脑膜炎奈瑟菌带菌状况调查 [J]. 中国生物制品学杂志,2021,34 (5): 571-574. [14] 谢娜,符文慧,朱兵清,等. 新疆维吾尔自治区1960—2019 年流行性脑脊髓膜炎流行病学及病原学特征分析[J]. 中华流行病学杂志,2021,42 (6): 1037-1043. [15] Xu Y, Li Y, Wang S, et al. Meningococcal vaccines in China[J]. Hum Vaccin Immunother, 2021, 17(7): 2197-2204. [16] 沈伟伟,王连华,邱春华,等. 2019 年浙江省台州市 1 例新生儿流行性脑脊髓膜炎病例病原学分析[J]. 疾病监测,2019,34 (10): 912-915. [17] Ladhani SN, Andrews N, Parikh SR, et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England[J]. N Engl J Med, 2020, 382(4): 309-317. [18] 莫巧茜,陈乐锋,黄金凤. 茂名市2020 年首例 Y 群流行性脑脊髓膜炎病例调查分析[J]. 海峡预防医学杂志,2024,30 (4): 73-75. [19] 张莉萍,叶雪仪,熊慧璋,等. 我国首例感染 Y 群脑膜炎奈瑟菌 cc23 病例的实验室分析 [J]. 疾病监测,2020,35 (7): 664-667. [20] Charles N, Jamie F, Paul B, et al. Evolution of invasive meningococcal disease epidemiology in Europe, 2008 to 2017[J]. Euro Surveill, 2022, 27(3): 2002075. [21] Coch GCA, Silvadelemos AP, Outeiro GMC, et al. Detection of Neisseria meningitidis in asymptomatic carriers in a university hospital from Brazil[J]. Rev Argent Microbiol, 2015, 47(4): 322-327. [22] 张颖,宋丽珍,刘桂芬,等. 山东省2007—2016 年实验室确诊流行性脑脊髓膜炎病例流行病学和临床特征分析[J]. 中华预防医学杂志,2019,53 (2): 169-173. [23] 骆金俊,吕静,李婷婷,等. 2013—2018 年湖北省健康人群脑膜炎奈瑟菌带菌率监测结果分析[J]. 应用预防医学,2021,27 (2): 180-182,184. [24] 王亚飞. 嘉祥县健康人群流脑带菌率调查及防控措施探讨 [J]. 中国保健营养,2019,29 (12): 311. [25] 刘然,方明礼,夏昕,等. 2008—2021 年湖南省健康人群脑膜炎奈瑟菌携带率和药物敏感性监测[J]. 中国疫苗和免疫,2023,29 (3): 326-331. [26] Coronell RW, Caceres D, Cintra O, et al. Epidemiology of invasive meningococcal disease in Colombia: A retrospective surveillance database analysis[J]. Infect Dis Ther, 2023, 12(12): 2709-2724. [27] Assefa S, Abdissa A, Alemu Y, et al. Neisseria meningitidis carriage rate, antibiotic susceptibility profile,associated factors among prisoners at Jimma zonal correction facility in Jimma Town, Southwestern Ethiopia: A cross-sectional study[J]. Trop Med Health, 2022, 50(1): 67. [28] McMillan M, Mohammed H, Bednarz J, et al. Longitudinal study of meningococcal carriage in adolescents and young adults in South Australia2017-2020[J]. J Infect, 2024, 88(2): 149-157. [29] Tefera Z, Mekonnen F, Tiruneh M, et al. Carriage rate of Neisseria meningitidis, antibiotic susceptibility pattern and associated risk factors among primary school children in Gondar town, Northwest Ethiopia[J]. BMC Infect Dis, 2020, 20(1): 358. [30] Azzari C, Moriondo M, Nieddu F, et al. Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: A five-year retrospective observational study (2014-2018)[J]. Vaccines (Basel), 2020, 8(3): 469. [31] 陈强,许燕,孙翔,等. 2019—2020 年江苏省健康人群脑膜炎奈瑟菌携带情况调查[J]. 中华预防医学杂志,2023,57 (2): 236-240. [32] Drew RJ, Bennett D, Odonnell S, et al. Risk factors for carriage of meningococcus in third-level students in Ireland: An unsupervised machine learning approach[J]. Hum Vaccin Immunother, 2021, 17(10): 3702-3709. [33] 徐丽,韩馥伊,吴丹,等. 2005—2019 年中国 538 株脑膜炎奈瑟菌抗生素耐药性分析[J]. 中华预防医学杂志,2021,55 (2): 207-211. [34] Chen M, Shao Y, Liu J, et al.Penicillin and cefotaxime resistance of quinolone-resistant Neisseria meningitidis clonal complex 4821, Shanghai, China, 1965-2020[J]. Emerg Infect Dis, 2023, 29(2): 341-350. |